Association between Circulating Ectodysplasin A and Diabetic Kidney Disease

Table 5

Results of multiple linear regression analysis for UACR in T2DM patients.

	Unadjusted			Adjusted by sex, smoking, hypertension, and drug use
	Age	-0.050	-0.012	0.990	-0.309	-0.112	0.911
Duration of T2DM	0.050	0.171	0.864	-0.199	-0.621	0.535
BMI	-0.378	-0.042	0.967	-7.047	-0.770	0.442
WHR	-125.909	-0.285	0.776	-10.684	-0.024	0.981
SBP	5.547	2.630	0.009	4.707	2.157	0.032
DBP	-0.154	-0.056	0.955	-0.307	-0.111	0.912
FPG	46.533	3.162	0.002	46.621	3.177	0.002
2hPG	-7.352	-1.136	0.257	-9.272	-1.432	0.154
FIns	1.915	0.379	0.705	3.413	0.673	0.501
2hIns	1.776	1.025	0.307	1.001	0.567	0.571
FC-P	-25.991	-0.600	0.549	5.068	0.115	0.909
2hCP	-17.887	-1.124	0.262	-15.851	-0.975	0.331
HbA1c	-35.207	-1.961	0.051	-29.117	-1.595	0.112
HOMA-IR	-16.664	-1.087	0.278	-19.659	-1.274	0.204
HOMA-β	0.043	0.945	0.346	0.046	1.005	0.316
TG	-16.327	-0.539	0.590	-20.536	-0.677	0.499
TC	160.083	1.967	0.050	168.239	2.063	0.040
HDL-C	-60.244	-0.610	0.543	-110.276	-1.091	0.277
LDL-C	-146.934	-1.604	0.110	-161.613	-1.751	0.081
ALT	-1.373	-0.630	0.529	-0.522	-0.235	0.815
AST	2.830	0.711	0.478	1.984	0.488	0.626
UA	-0.212	-0.533	0.595	-0.237	-0.594	0.553
BUN	6.567	0.435	0.664	2.510	0.165	0.869
Creatinine	5.152	2.723	0.007	7.482	3.166	0.002
eGFR	-1.648	-0.914	0.362	0.236	0.109	0.913
EDA	0.543	2.475	0.014	0.495	2.248	0.026